Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

2.

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WM; Authors/Task Force Members.

Eur Heart J. 2016 Aug 1;37(29):2315-81. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23. No abstract available.

3.

Applicability of the Existing CVD Risk Assessment Tools to Type II Diabetics in Oman: A Review.

Al-Rawahi A, Lee P.

Oman Med J. 2015 Sep;30(5):315-9. doi: 10.5001/omj.2015.65. Review.

4.

Interpreting Hemoglobin A1C in Combination With Conventional Risk Factors for Prediction of Cardiovascular Risk.

Jarmul JA, Pignone M, Pletcher MJ.

Circ Cardiovasc Qual Outcomes. 2015 Sep;8(5):501-7.

5.

Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus.

Lorber D.

Diabetes Metab Syndr Obes. 2014 May 23;7:169-83. doi: 10.2147/DMSO.S61438. eCollection 2014. Review.

6.

Screening strategies for cardiovascular disease in asymptomatic adults.

Wallace ML, Ricco JA, Barrett B.

Prim Care. 2014 Jun;41(2):371-97. doi: 10.1016/j.pop.2014.02.010. Epub 2014 Mar 27. Review.

7.

Glycated hemoglobin measurement and prediction of cardiovascular disease.

Emerging Risk Factors Collaboration, Di Angelantonio E, Gao P, Khan H, Butterworth AS, Wormser D, Kaptoge S, Kondapally Seshasai SR, Thompson A, Sarwar N, Willeit P, Ridker PM, Barr EL, Khaw KT, Psaty BM, Brenner H, Balkau B, Dekker JM, Lawlor DA, Daimon M, Willeit J, Njølstad I, Nissinen A, Brunner EJ, Kuller LH, Price JF, Sundström J, Knuiman MW, Feskens EJ, Verschuren WM, Wald N, Bakker SJ, Whincup PH, Ford I, Goldbourt U, Gómez-de-la-Cámara A, Gallacher J, Simons LA, Rosengren A, Sutherland SE, Björkelund C, Blazer DG, Wassertheil-Smoller S, Onat A, Marín Ibañez A, Casiglia E, Jukema JW, Simpson LM, Giampaoli S, Nordestgaard BG, Selmer R, Wennberg P, Kauhanen J, Salonen JT, Dankner R, Barrett-Connor E, Kavousi M, Gudnason V, Evans D, Wallace RB, Cushman M, D'Agostino RB Sr, Umans JG, Kiyohara Y, Nakagawa H, Sato S, Gillum RF, Folsom AR, van der Schouw YT, Moons KG, Griffin SJ, Sattar N, Wareham NJ, Selvin E, Thompson SG, Danesh J.

JAMA. 2014 Mar 26;311(12):1225-33. doi: 10.1001/jama.2014.1873.

8.

Predictive value of updating Framingham risk scores with novel risk markers in the U.S. general population.

Ferket BS, van Kempen BJ, Hunink MG, Agarwal I, Kavousi M, Franco OH, Steyerberg EW, Max W, Fleischmann KE.

PLoS One. 2014 Feb 18;9(2):e88312. doi: 10.1371/journal.pone.0088312. eCollection 2014.

9.

Trends in laboratory test volumes for Medicare Part B reimbursements, 2000-2010.

Shahangian S, Alspach TD, Astles JR, Yesupriya A, Dettwyler WK.

Arch Pathol Lab Med. 2014 Feb;138(2):189-203. doi: 10.5858/arpa.2013-0149-OA. Epub 2013 Jun 5.

10.

Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance.

Carver JR, Szalda D, Ky B.

Semin Oncol. 2013 Apr;40(2):229-38. doi: 10.1053/j.seminoncol.2013.01.005.

11.

The role of carotid intimal thickness testing and risk prediction in the development of coronary atherosclerosis.

Darabian S, Hormuz M, Latif MA, Pahlevan S, Budoff MJ.

Curr Atheroscler Rep. 2013 Mar;15(3):306. doi: 10.1007/s11883-012-0306-4. Review.

12.

Yield of screening for coronary artery calcium in early middle-age adults based on the 10-year Framingham Risk Score: the CARDIA study.

Okwuosa TM, Greenland P, Ning H, Liu K, Lloyd-Jones DM.

JACC Cardiovasc Imaging. 2012 Sep;5(9):923-30. doi: 10.1016/j.jcmg.2012.01.022.

13.

Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.

Wang TJ, Wollert KC, Larson MG, Coglianese E, McCabe EL, Cheng S, Ho JE, Fradley MG, Ghorbani A, Xanthakis V, Kempf T, Benjamin EJ, Levy D, Vasan RS, Januzzi JL.

Circulation. 2012 Sep 25;126(13):1596-604. Epub 2012 Aug 20.

14.

Coronary artery calcium and primary prevention risk assessment: what is the evidence? An updated meta-analysis on patient and physician behavior.

Whelton SP, Nasir K, Blaha MJ, Gransar H, Metkus TS, Coresh J, Berman DS, Blumenthal RS.

Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):601-7. doi: 10.1161/CIRCOUTCOMES.112.965566. Review. No abstract available.

15.

Fasting glucose, obesity, and coronary artery calcification in community-based people without diabetes.

Rutter MK, Massaro JM, Hoffmann U, O'Donnell CJ, Fox CS.

Diabetes Care. 2012 Sep;35(9):1944-50. doi: 10.2337/dc11-1950. Epub 2012 Jul 6.

16.

Improving interMediAte risk management. MARK study.

Martí R, Parramon D, García-Ortiz L, Rigo F, Gómez-Marcos MA, Sempere I, García-Regalado N, Recio-Rodriguez JI, Agudo-Conde C, Feuerbach N, Garcia-Gil M, Ponjoan A, Quesada M, Ramos R.

BMC Cardiovasc Disord. 2011 Oct 13;11:61. doi: 10.1186/1471-2261-11-61.

17.

Atherosclerosis screening by noninvasive imaging for cardiovascular prevention: a systematic review.

Rodondi N, Auer R, de Bosset Sulzer V, Ghali WA, Cornuz J.

J Gen Intern Med. 2012 Feb;27(2):220-31. doi: 10.1007/s11606-011-1833-3. Epub 2011 Sep 1. Review.

18.
19.

Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004.

Pande RL, Perlstein TS, Beckman JA, Creager MA.

Circulation. 2011 Jul 5;124(1):17-23. doi: 10.1161/CIRCULATIONAHA.110.003954. Epub 2011 Jun 20.

20.

Ankle brachial index screening in asymptomatic older adults.

Taylor-Piliae RE, Fair JM, Varady AN, Hlatky MA, Norton LC, Iribarren C, Go AS, Fortmann SP.

Am Heart J. 2011 May;161(5):979-85. doi: 10.1016/j.ahj.2011.02.003.

Supplemental Content

Support Center